Porth's Essentials of Pathophysiology, 4e

70

Cell and Tissue Function

U N I T 1

18. Harper CR, Jacobson TA. Usefulness of omega-3 fatty acids and prevention of coronary heart disease. Am J Cardiol. 2005;96:1521–1529. 19. Gosain A, Gamelli RL. A primer on cytokines. J Burn Care Rehabil. 2005;26:7–12. 20. Charo I, Ransohoff RM. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med. 2006;354(6):610–621. 21. Serhan CN, Savill J. Resolution of inflammation: the beginning programs the end. Nat Immunol. 2005;6(12):1191–1197. 22. Serhan CN, Brain SD, Buckley CD, et al. Resolution of inflammation: state of the art, definitions and terms. FASEB J. 2007;21:325–332. 23. Schottenfeld D, Beebe-Dimmer J. Chronic inflammation: a common and important factor in the pathogenesis of neoplasia. CA Cancer J Clin. 2006;56:69–83. 24. Nathan C. Epidemic inflammation: pondering obesity. Mol Med. 2008;7(8):485–492. 25. Tateya S, Kim F, Tamori Y. Recent advances in obesity- related inflammation and insulin resistance. Front Endocrinol (Lausanne). 2013;4:93. 26. Greenberg AS, Obin MS. Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr. 2006;83(suppl):461S–465S. 27. Ridker PM. C-reactive protein, inflammation, and cardiovascular disease. Curr Issues Cardiol. 2005;32(3):384–386. 28. Ridker PM. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in primary prevention of cardiovascular disease. Circulation. 2001;103:1813–1818. 29. Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107:499–511. 30. Hotchiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med. 2003;348(2):138–150. 31. Hall JE. Guyton and Hall Textbook of Medical Physiology . 12th ed. Philadelphia, PA: Saunders Elsevier; 2011:867–877. 32. Wilzmann FA. The regulation of body temperature. In: Rhoades RA, Bell DR. Medical Physiology . 2nd ed. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2013:550–574. 33. Roth J, Rummel C, Barth SW, et al. Molecular aspects of fever and hyperthermia. Neurol Clin. 2006;24:421–439. 34. Blatteis CM. Endotoxic fever: new concepts of its regulation suggest new approaches to its management. Pharmacol Ther. 2006;111:194–223.

35. Blatteis CM, Li S, Li Z, et al. Cytokines, PGE 2 , and endotoxic fever: a re-assessment. Prostaglandins Other Lipid Mediat. 2005;76:1–18. 36. Thompson HJ, Pinto-Martin J, Bullock MR. Neurogenic fever after traumatic brain 2011 injury: an epidemiological study. J Neurol Neurosurg Psychiatry. 2003;74:614–619. 37. Ogoina D. Fever, fever patterns and 2011 diseases called “fever”—A review. J Infect Public Health 2011;4(3):108–124. 38. Patel R, Gallagher JC. Drug fever. Pharmacotherapy. 2010;30(1):57–69. 39. Graves RC, Oehler K, Tingle LE. Febrile seizures: risks, evaluation, and prognosis. Am Fam Physician. 2012;85(2):149–153. 40. Cunha BA. Fever of unknown origin: clinical overview of and classic and current concepts. Infect Dis Clin North Am. 2007;21:867–915. 41. Horowitz HW. Fever of unknown origin or fever of too many origins. N Engl J Med. 2013;368(3):197–199. 42. Hamilton JL, John SP. Evaluation of fever in infants and young children. Am Fam Physician. 2013;87(4):254–260. 43. Ishimine P. Fever without source in children 0 to 36 months of age. Pediatr Clin North Am. 2006;53:167–194. 44. ACEP Clinical Policy Committee and Clinical Policies 45. Woolery WA, Franco FR. Fever of unknown origin: keys to determining the etiology in older patients. Geriatrics. 2004;59(10):41–45. 46. Norman DC, Wong MG, Yoshikawa TT. Fever of unknown origin in older persons. Infect Dis Clin North Am. 2007;21:937–945. 47. Outzen M. Management of fever in older adults. J Gerontol Nurs. 2009;35(5):17–23. Subcommittee on Pediatric Care. Clinical policy for children less than 3 years presenting to the emergency department with fever. Ann Emerg Med. 2003;42(4):530–545.

Porth Essentials Resources Explore these additional resources to enhance learning for this chapter: •  NCLEX-Style Questions and Other Resources

on

, http://thePoint.lww.com/PorthEssentials4e

• Study Guide for Essentials of Pathophysiology • Concepts in Action Animations • Adaptive Learning | Powered by PrepU, http://thepoint.lww.com/ prepu